Results 221 to 230 of about 1,414,184 (301)

When red flags become rules: managing diagnostic uncertainty in primary care. [PDF]

J R Soc Med
Jerjes W, Majeed A.
europepmc   +1 more source

Japan’s influence on Korea’s judicial modernization examining the reality of judicial modernization by analyzing legal cases in the late nineteenth century [PDF]

, 2012
Junghoon, Lee
core  

Population pharmacokinetic modelling of amoxicillin in human breast milk—A contribution from the ConcePTION project

British Journal of Clinical Pharmacology, EarlyView.
Aims Amoxicillin, a widely used β‐lactam antibiotic, requires improved pharmacokinetic characterization during breastfeeding. This study used a population pharmacokinetic (PopPK) approach to model amoxicillin concentrations in breast milk, identify variability sources and estimate infant exposure, applying worst‐case scenarios.
Sarah Baklouti, Virginie Rigourd, Alice Panchaud, Hedvig Nordeng, Karel Allegaert, Pieter Annaert, Miao‐Chan Huang, Anaelle Monfort, Monia Guidi, Peggy Gandia   +9 more
wiley   +1 more source

Identifying Key Indicators and Components of Earthquake Preparedness Exercises in the Prehospital Setting: An Exploratory Content Analysis From Paramedic Nurses' Perspectives. [PDF]

Nurs Res Pract
Aminafshar A, Khosravizad A, Sahebi A, Nekoeimoghadam M, Amiresmaili M, Tavan A, Farahmandnia H.   +6 more
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Techno-Mainstreaming Palliative Care: The Global Palliative Doctors' Network. [PDF]

J Epidemiol Glob Health
Ebrahim SH, Rahman M, Banoo S, Rivera BD, Baylon-Mallillin MM, Begum N, Desh P, Govender T, Badarudeen S, Memish Z, Global Palliative Doctors Network.   +10 more
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

When Policy Meets Reality: Municipal Leaders' Views Amid Rising LTC Expenditure. [PDF]

Health Serv Insights
Tjerbo T, Hagen TP, Holte JH.
europepmc   +1 more source

Clinician's attitudes & perspective on chemical adherence testing in hypertension (CATCH): A qualitative interview study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Chemical Adherence Testing (CAT) is gaining prominence as a reliable and valid clinical method to detect whether antihypertensive agents are being taken as prescribed. This study aimed to explore clinicians' attitudes and perspectives on the clinical use of CAT.
Roshan Shahab, Louise Rabbitt, Gerard J. Molloy   +2 more
wiley   +1 more source

Artificial Intelligence in Medical Education: Transformative Potential, Current Applications, and Future Implications.

JMIR Med Educ
Izquierdo-Condoy JS, Arias-Intriago M, Montero Corrales L, Ortiz-Prado E.   +3 more
europepmc   +1 more source